CREDIT Features

Manages massive amounts of data from patient registration to compliance to cost.

Robust reporting capability that is fully customizable.

Offers a library of over 3,400 protocols including both cooperative group and industry-sponsored.

Web-based system utilizing HIPAA-compliant servers, accessible via all commonly-used browsers.

Complete tracking of IRB review dates and actions for all protocols and subsequent addenda and revisions, including automatic flagging of all patients affected by a protocol revision or review (e.g. reconsenting.)

Comprehensive financials module includes invoicing, payment allocation, billing compliance, and financial analysis.

Fully customizable with an unlimited number of data fields.

Partnering With Users

CREDIT© was developed and continues as a collaborative effort between DDOTS and its member research institutions. Our customers are really “members” of a dynamic DDOTS organization. CREDIT© was created with a vision of building software that would incorporate ongoing improvement and exponential growth based upon practical need. For 20+ years, DDOTS users have been submitting suggestions for updates and additional functional capabilities on an ongoing basis. Our DDOTS IT staff work continuously to incorporate the requested program elements, releasing new updates every 14 days. This makes CREDIT© unique and relevant in today’s fast-paced and increasingly complex field of clinical trials – everyone shares in “best practice.”

Oncology Clinical Trials Expertise

CREDIT© had its origin in oncology and continues today as the premiere web-based software for community sites supported by the National Cancer Institute Community Oncology Research Program. CREDIT was developed through funding from Phase I and Phase II cooperative agreements with the NCI.   

A Strategic Product Focus

DDOTS takes a broad, dynamic approach to ongoing software development, recognizing the importance of meeting current – and often expanding -- standards for clinical trials data management and implementation elements. That is why CREDIT© is relevant to a broad spectrum of users, from health care systems to pharmaceutical companies and physicians in private practice. Our constant communication with user “members” facilitates our ability to remain current with regard to clinical trials research, forming the basis for innovative yet practical product design.

DDOTS monitors grant application and program requirements for federal funding, working with applicants to ensure that required data can be easily extracted from their CREDIT© database (e.g., race and ethnicity tracking, quality and costs, cancer disparities research.)  Additionally, Clinical trials programs that conduct pharmaceutical or industry-sponsored research must be able to collect various data elements specific to private industry, and DDOTS collaborates to assure that CREDIT© incorporates the capabilities that entail minimal effort to document compliance.

Monitoring Clinical Trials Program Quality

In the world of clinical research, the ability to maintain strict compliance with protocols and pristine data quality is critical. CREDIT© allows users to track adherence to protocol requirements each and every step of the way from patient treatment plans to required regulatory (IRB) notifications (e.g., reconsent).   Individual schedules are developed for each patient, automatically adjusting for treatment delays. Monitoring of timely data submissions is simple, eliminating queries from research sponsors.   

The ability to monitor quality is endless. Your CREDIT© database can be utilized to access a myriad of data for just about any QI projects you design, from determining time from patient diagnosis to treatment or improving the billing process for study-related tests.